1Pai AB, Pai MP. Optimizing antimierobial therapy for gram-positive bloodstream infections in patients on hemodialysis [ J ]. Advances in Chronic Kidney Disease,2006,13:259 -270. 被引量：1
2Dominguez MC ,de La Rosa M ,Borobio MV. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar[ J]. J Antimicrob Chemother,2001,47:391 - 398. 被引量：1
3Odenholt I, Cars O. Pharmacodynamics of moxifloxacin and levo- floxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli:simulation of human plasma concentrations after intravenous dosage in an in vitro kinet- ic model [ J ]. J Antimicrob Chemother, 2006,58 ( 5 ) : 960 - 965. 被引量：1
4Boswell FJ,Andrews JM, Wise R, et al. Bactericidal properties of moxifloxacin and post-antibiotic effect[ J]. J Antimicrob Chemother, 1999,43:43 - 49. 被引量：1
5Chu DTW. Recent developments in macrolides and ketolides [ J ]. Curt opin Microbiol, 1999,2:467. 被引量：1
6Campion JJ, McNamara PJ, Evans ME. Evolution of ciprofloxacin- resistant Staphylococcus aureus in vivo pharmacokinetic environ- ments [ J ]. Antimicrob Agents Chemother,2004,48:4733 - 4744. 被引量：1
7Drlica K. The mutant selection window and antimicrobial resistance [J]. J Antimicrob Chemother,2003,52 : 11 - 17. 被引量：1
